Stergioula, A.; Kormas, T.; Kokkali, S.; Memos, N.; Pantelis, E.; Pouloudi, D.; Agrogiannis, G.
What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC–STBSG Response Score. Cancers 2024, 16, 3449.
https://doi.org/10.3390/cancers16203449
AMA Style
Stergioula A, Kormas T, Kokkali S, Memos N, Pantelis E, Pouloudi D, Agrogiannis G.
What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC–STBSG Response Score. Cancers. 2024; 16(20):3449.
https://doi.org/10.3390/cancers16203449
Chicago/Turabian Style
Stergioula, Anastasia, Theodoros Kormas, Stefania Kokkali, Nikolaos Memos, Evaggelos Pantelis, Despina Pouloudi, and Georgios Agrogiannis.
2024. "What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC–STBSG Response Score" Cancers 16, no. 20: 3449.
https://doi.org/10.3390/cancers16203449
APA Style
Stergioula, A., Kormas, T., Kokkali, S., Memos, N., Pantelis, E., Pouloudi, D., & Agrogiannis, G.
(2024). What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC–STBSG Response Score. Cancers, 16(20), 3449.
https://doi.org/10.3390/cancers16203449
